Fetal Membrane Edema (Hydrallantois / Hydrops Amnii)

Fetal membrane edema, encompassing hydrallantois (hydrops allantois) and hydrops amnii (hydrops amnion), is a pathological accumulation of excessive fluid within the allantoic or amniotic cavities, respectively, during pregnancy. In veterinary theriogenology, this condition is most commonly recognized in ruminants (cattle, sheep, goats) and occasionally in horses, swine, and small animals (dogs and cats). The normal volume of allantoic fluid in a term bovine pregnancy is approximately 4-8 liters, while amniotic fluid is about 1-2 liters; in hydrallantois, allantoic fluid can exceed 20-100 liters, and in hydrops amnii, amniotic fluid may reach 10-20 liters. The condition is characterized by progressive, often rapid abdominal distension due to fluid accumulation, leading to maternal metabolic, respiratory, and circulatory compromise. Hydrallantois is more common than hydrops amnii and typically arises from placental dysfunction, whereas hydrops amnii is often associated with fetal anomalies or fetal inability to swallow amniotic fluid. The pathophysiological mechanisms involve imbalances in fluid production and resorption across the fetal membranes, often secondary to placental insufficiency, fetal renal or cardiovascular abnormalities, or maternal systemic disease. Clinically, the condition presents as a dystocia-like syndrome with severe abdominal enlargement, reluctance to move, dyspnea, and signs of hypovolemic shock in advanced cases. Early diagnosis via ultrasonography and radiography is critical for management, which may include medical therapy (e.g., prostaglandins, corticosteroids) or surgical intervention (cesarean section or ovariohysterectomy) depending on the species, gestational stage, and severity. Prognosis is guarded to poor for both dam and fetus, especially in advanced cases, and prompt intervention is essential to prevent maternal death.

The etiology of fetal membrane edema is multifactorial and varies by species and type (hydrallantois vs. hydrops amnii). In cattle, hydrallantois is most frequently associated with placental insufficiency due to chronic placentitis, often caused by bacterial infections such as Trueperella pyogenes, Streptococcus spp., or Escherichia coli, which disrupt the placental barrier and alter fluid dynamics. Additionally, maternal cardiovascular diseases, such as chronic heart failure or hypertension, can lead to increased hydrostatic pressure and fluid transudation into the allantoic cavity. Fetal factors, including congenital anomalies of the urinary tract (e.g., renal agenesis, ureteral obstruction) or cardiovascular defects, can impair fetal urine production or circulation, contributing to fluid accumulation. In hydrops amnii, the primary etiology is often fetal inability to swallow amniotic fluid due to congenital defects such as cleft palate, esophageal atresia, or neural tube defects, leading to excessive amniotic fluid. In small animals, hydrallantois is rare but may occur secondary to placental insufficiency, fetal anomalies, or maternal systemic diseases like renal failure or hypoproteinemia. Iatrogenic causes, such as excessive administration of corticosteroids or prostaglandins, have been implicated in some cases. Genetic predisposition has been suggested in certain bovine breeds, particularly Holstein-Friesian, but a definitive hereditary basis is not established. In horses, hydrops amnii is occasionally seen with twin pregnancies or placental abnormalities. The exact molecular mechanisms involve dysregulation of aquaporins and ion channels in the fetal membranes, leading to altered water and electrolyte transport. Endocrine factors, including imbalances in fetal cortisol, aldosterone, and antidiuretic hormone, may also play a role. Overall, the etiology is complex and often idiopathic, with multiple contributing factors.

Fetal membrane edema is a sporadic but potentially fatal condition of pregnancy, with a higher reported incidence in cattle, particularly in dairy breeds such as Holstein-Friesian and Jersey. The incidence in cattle is estimated at 0.01% to 0.1% of pregnancies, with hydrallantois being more common than hydrops amnii. The condition is more frequently observed in pluriparous cows, with a peak incidence between 5 and 8 years of age, and is often associated with multiple pregnancies (twins) or fetal giantism. In horses, hydrops amnii is rare, with an incidence of less than 0.1%, and is more common in older mares and those with a history of placental disease. In small animals, the condition is extremely rare, with only isolated case reports in dogs and cats, often associated with fetal anomalies or maternal systemic disease. Breed predispositions are not well-documented, but in cattle, Holstein-Friesian and other high-producing dairy breeds appear to be overrepresented, possibly due to metabolic stress and higher incidence of placental pathology. No clear sex predilection exists, as the condition affects the dam. Parity is a significant risk factor, with multiparous animals being more commonly affected, likely due to cumulative uterine and placental damage. Seasonal variations have not been consistently reported. The condition is more likely to be diagnosed in well-managed herds with regular veterinary surveillance, as early signs may be subtle. In beef cattle, the incidence may be lower due to less intensive management. Overall, the epidemiology suggests a multifactorial etiology with both maternal and fetal components, and the condition is a significant cause of late-gestation abortion, dystocia, and maternal mortality if not managed promptly.

The pathophysiology of fetal membrane edema involves a complex interplay of fetal, placental, and maternal factors that disrupt the normal balance of fluid production and resorption within the fetal compartments. In hydrallantois, the primary defect is often placental insufficiency, leading to increased permeability of the allantoic membrane and altered hydrostatic and oncotic pressures. Normally, allantoic fluid is produced by fetal urine and fetal renal excretion, and resorbed via the allantoic epithelium and fetal swallowing. When placental function is compromised, as in chronic placentitis or maternal cardiovascular disease, there is an increase in hydrostatic pressure in the fetal capillaries and a decrease in oncotic pressure due to hypoproteinemia, leading to excessive transudation of fluid into the allantoic cavity. Additionally, dysfunction of aquaporins and ion channels in the allantoic epithelium can impair fluid resorption. In hydrops amnii, the primary mechanism is often fetal inability to swallow amniotic fluid, which is normally a major route of fluid removal. This can result from congenital anomalies such as esophageal atresia, cleft palate, or neural tube defects, or from fetal neuromuscular disorders. The accumulation of amniotic fluid leads to increased intrauterine pressure, which can compress the umbilical cord and impair fetal circulation, leading to fetal hypoxia and distress. The expanding uterus also compresses the maternal abdominal organs, particularly the rumen in ruminants, leading to anorexia and metabolic disturbances. The increased intra-abdominal pressure impairs venous return to the heart, causing maternal hypotension, tachycardia, and respiratory compromise. In advanced cases, the excessive fluid can cause uterine rupture or diaphragmatic hernia. The condition is also associated with maternal systemic inflammation, as placental insufficiency can release pro-inflammatory cytokines, leading to a systemic inflammatory response syndrome. Endocrine changes, including elevated maternal cortisol and prostaglandins, may contribute to the progression of the condition. Ultimately, the pathophysiology results in a vicious cycle of fluid accumulation, increased intrauterine pressure, and maternal-fetal compromise, which, if untreated, leads to fetal death and maternal mortality.

Several intrinsic and extrinsic factors predispose animals to fetal membrane edema. Intrinsic factors include advanced maternal age, particularly in cattle over 5 years, and multiparity, as repeated pregnancies may lead to uterine and placental damage. Genetic predisposition is suggested by a higher incidence in certain breeds, such as Holstein-Friesian cattle, and in families with a history of the condition. Fetal factors, such as congenital anomalies of the urinary, gastrointestinal, or cardiovascular systems, are significant predisposing factors, especially for hydrops amnii. Multiple pregnancies (twins or triplets) increase the risk, likely due to placental competition and insufficiency. Maternal systemic diseases, including chronic heart failure, renal disease, liver disease, and hypoproteinemia, can predispose to fluid accumulation by altering hydrostatic and oncotic pressures. Endocrine imbalances, such as hypothyroidism or hyperadrenocorticism, may also contribute. Extrinsic factors include poor nutritional status, particularly protein deficiency, which can lead to hypoproteinemia and reduced oncotic pressure. Infectious agents, such as bacteria causing placentitis, are important predisposing factors, especially in cattle. Iatrogenic factors, such as excessive administration of corticosteroids or prostaglandins during pregnancy, have been implicated. Environmental stressors, including heat stress, overcrowding, and poor hygiene, can increase the risk of placental infections. In small animals, obesity and poor maternal health are potential risk factors. Additionally, a history of dystocia or retained fetal membranes may predispose to placental pathology. Overall, the condition is multifactorial, and the presence of one or more of these factors increases the likelihood of developing fetal membrane edema.

The clinical signs of fetal membrane edema are primarily related to the progressive accumulation of fluid within the uterus, leading to abdominal distension and secondary maternal compromise. The onset is usually insidious, with a gradual increase in abdominal size over several weeks, but can be rapid in severe cases. The most prominent sign is a bilateral, symmetrical, and tense abdominal enlargement, which may be mistaken for a normal late-term pregnancy but is disproportionately large for the gestational stage. In cattle, the abdomen may become so distended that the animal has difficulty rising, walking, or lying down. Affected animals often show a 'sawhorse' stance, with the back arched and the limbs spread to support the weight. Respiratory distress is common due to pressure on the diaphragm, leading to tachypnea, dyspnea, and shallow breathing. The increased intra-abdominal pressure also compresses the rumen, causing anorexia, decreased rumen motility, and bloat. In advanced cases, there may be signs of hypovolemic shock, including tachycardia, weak pulse, pale mucous membranes, and cold extremities. The animal may become recumbent and unable to rise. In some cases, there is a vaginal discharge, which may be serous or bloody, due to rupture of the fetal membranes. On rectal palpation in cattle, the uterus is felt as a large, fluid-filled sac, and the fetus may be difficult to palpate due to the excessive fluid. In small animals, the clinical signs are similar, with abdominal distension, lethargy, and anorexia. The condition can also cause maternal hypertension and proteinuria, resembling preeclampsia. In severe cases, uterine rupture can occur, leading to acute abdominal pain, collapse, and death. The fetus is often compromised, and fetal death may occur, leading to maceration or mummification. The clinical signs are progressive and, if left untreated, result in maternal death due to respiratory failure, circulatory collapse, or uterine rupture.

The differential diagnoses for fetal membrane edema include conditions that cause excessive abdominal distension during pregnancy. Key differentials include: 1) Normal pregnancy with multiple fetuses (e.g., twins or triplets), which can cause similar abdominal enlargement, but the size is usually less extreme and the condition is not progressive. 2) Fetal giantism or fetal ascites, which can cause abdominal distension but is usually associated with a single large fetus, and ultrasonography can differentiate. 3) Uterine torsion, which presents with acute abdominal pain and signs of shock, and can be diagnosed by vaginal or rectal palpation. 4) Abdominal neoplasia, such as uterine leiomyoma or ovarian tumors, which can cause abdominal enlargement but are usually not associated with pregnancy. 5) Peritonitis, which may cause abdominal distension due to fluid accumulation, but is accompanied by fever, pain, and systemic signs. 6) Ascites due to liver disease or heart failure, which can cause abdominal distension but is not confined to the uterus. 7) Hydrometra or mucometra, which is an accumulation of fluid in the uterus in non-pregnant animals, but can be differentiated by the absence of a fetus and the presence of a closed cervix. 8) Fetal mummification or maceration, which may cause abdominal distension but is usually associated with a history of fetal death and a smaller uterine size. 9) Abdominal hernia or diaphragmatic hernia, which can cause abdominal enlargement but is usually associated with a palpable defect. 10) Obesity, which can cause abdominal distension but is not progressive and is not associated with pregnancy. Diagnostic tools such as ultrasonography, radiography, and hormonal assays are essential to differentiate these conditions. Ultrasonography can confirm the presence of excessive fluid within the fetal membranes and assess fetal viability. Radiography can reveal the fetal skeleton and the extent of fluid accumulation. Hormonal assays, such as progesterone and estrogen, can help confirm pregnancy and assess placental function.

The diagnostic algorithm for fetal membrane edema begins with a thorough history and physical examination, focusing on the stage of gestation, parity, and the rate of abdominal enlargement. The presence of progressive, excessive abdominal distension in a pregnant animal should raise suspicion. The next step is transrectal palpation in large animals, which may reveal a large, fluid-filled uterus with a fetus that is difficult to palpate due to the excessive fluid. In small animals, abdominal palpation may reveal a large, tense uterus. Ultrasonography is the most valuable diagnostic tool, as it can confirm the presence of excessive fluid within the allantoic or amniotic cavities, measure the depth of fluid, assess fetal viability (heart rate, movement), and detect fetal anomalies. In cattle, the normal allantoic fluid depth is less than 5 cm, while in hydrallantois, it may exceed 10 cm. Radiography can be used to assess the fetal skeleton and the extent of fluid accumulation, but it is less sensitive than ultrasonography. Laboratory tests, including complete blood count, serum biochemistry, and urinalysis, can help assess maternal health and identify underlying conditions such as hypoproteinemia or renal disease. Hormonal assays, such as progesterone and estrogen, can confirm pregnancy and assess placental function; in cases of placental insufficiency, progesterone levels may be low. Amniocentesis or allantocentesis can be performed to analyze the fluid for cytology, culture, and biochemical markers, but this is rarely necessary and carries risks. In cases where the diagnosis is uncertain, a differential diagnosis should be considered, and additional imaging such as MRI or CT may be used in small animals. The diagnostic algorithm should also include a fetal stress assessment, such as fetal heart rate monitoring, to determine fetal viability and guide management decisions. If the condition is diagnosed, the clinician should assess the severity and decide on the appropriate treatment, which may include medical management or surgical intervention.

Laboratory findings in fetal membrane edema are variable and reflect the underlying pathophysiology and maternal systemic effects. Hematology may reveal hemoconcentration due to dehydration, with increased packed cell volume and total protein, or conversely, anemia due to hemodilution in cases of severe fluid accumulation. Leukocytosis with a left shift may be present if there is an underlying infection, such as placentitis. Serum biochemistry often shows hypoproteinemia, particularly hypoalbuminemia, due to protein loss into the uterine fluid or decreased hepatic synthesis. In advanced cases, there may be evidence of renal dysfunction, such as elevated blood urea nitrogen and creatinine, due to decreased renal perfusion. Liver enzymes may be elevated if there is hepatic congestion or fatty liver disease. Electrolyte imbalances, including hyponatremia, hypokalemia, and hypochloremia, can occur due to fluid shifts and renal losses. Metabolic acidosis may develop due to lactic acidosis from poor tissue perfusion. In cattle, ketosis may be present due to anorexia and negative energy balance. Urinalysis may reveal proteinuria, which can be significant, and in some cases, ketonuria. Hormonal assays may show decreased serum progesterone levels if there is placental insufficiency, and elevated cortisol levels due to stress. In cases of hydrops amnii, alpha-fetoprotein levels may be elevated, but this is not routinely measured. Vaginal cytology may show a mixture of parabasal, intermediate, and superficial cells, with an increased number of neutrophils if there is inflammation. Uterine fluid analysis, if obtained, may show a transudate or modified transudate with low cellularity and low protein content in hydrallantois, or a more cellular fluid in cases of infection. Culture of uterine fluid or vaginal swabs may reveal bacterial pathogens. Overall, laboratory findings are nonspecific but can support the diagnosis and help assess the severity of the condition and guide treatment.

Imaging plays a crucial role in the diagnosis and management of fetal membrane edema. Abdominal ultrasonography is the primary imaging modality and can provide detailed information about the fetal membranes, fluid volume, and fetal well-being. In normal pregnancy, the allantoic fluid is anechoic and the amniotic fluid is hypoechoic, with a depth of less than 5 cm in cattle. In hydrallantois, the allantoic fluid is excessive, often with a depth greater than 10 cm, and may contain floating echogenic particles due to cellular debris. In hydrops amnii, the amniotic fluid is excessive, and the fetus may be seen floating in a large anechoic cavity. Ultrasonography can also assess fetal viability by measuring fetal heart rate; a normal fetal heart rate in cattle is 100-140 beats per minute, and a rate below 100 bpm indicates fetal distress. Fetal movement and tone can also be assessed. The uterine wall may appear thin and stretched, and the placenta may show signs of thickening or detachment. In small animals, ultrasonography can similarly assess the fluid volume and fetal viability. Radiography is less sensitive but can be useful in advanced cases, showing a large, homogeneous soft tissue opacity in the abdomen with a fetal skeleton visible if the fetus is mineralized (after day 45 in cattle). The fetal skeleton may appear compressed or displaced to the periphery due to the excessive fluid. Radiography can also help rule out other causes of abdominal distension, such as fetal emphysema or abdominal neoplasia. In small animals, CT or MRI may be used for more detailed imaging, but this is rarely necessary. Vaginoscopy can be performed to assess the cervix and vaginal mucosa, but it is not diagnostic for fetal membrane edema. Overall, ultrasonography is the gold standard for diagnosis and monitoring, and it should be performed serially to assess the progression of the condition and the response to treatment.

Cytology and histopathology are not commonly used for the diagnosis of fetal membrane edema, but they can provide valuable information in certain cases. Vaginal cytology may be performed to assess the stage of the estrous cycle and to detect inflammation or infection. In a pregnant animal with fetal membrane edema, vaginal cytology may show a mixture of parabasal, intermediate, and superficial cells, with an increased number of neutrophils if there is an underlying placentitis. The presence of bacteria may also be noted. Amniotic or allantoic fluid analysis can be performed via ultrasound-guided aspiration, and cytology of the fluid may reveal a low cellularity with predominantly epithelial cells and occasional neutrophils. The fluid is typically a transudate with low protein content in hydrallantois, but may be more cellular and proteinaceous if there is infection. Histopathology of the placenta and fetal membranes, if available after abortion or necropsy, can reveal characteristic changes. In hydrallantois, the allantoic epithelium may show degenerative changes, with vacuolation and desquamation of epithelial cells. The underlying connective tissue may be edematous and infiltrated with inflammatory cells. In cases of placentitis, there may be suppurative inflammation with necrosis and thrombosis of placental vessels. In hydrops amnii, the amniotic epithelium may be normal, but the fetus may show congenital anomalies. Histopathology of the fetal kidneys may reveal renal dysplasia or other anomalies. In cases of maternal systemic disease, such as hypoproteinemia, the liver may show fatty change or cirrhosis. Overall, cytology and histopathology are not essential for diagnosis but can help identify the underlying etiology and guide management.

The treatment of fetal membrane edema depends on the species, gestational stage, severity, and the goals of the owner (e.g., salvage of the dam vs. fetus). In all cases, the primary goal is to stabilize the dam and address the fluid accumulation. Medical management may be attempted in early or mild cases, particularly in cattle, with the aim of inducing parturition or abortion. Prostaglandin F2α (PGF2α) is commonly used to induce luteolysis and parturition. In cattle, dinoprost tromethamine (Lutalyse) is administered at a dose of 25 mg IM, or cloprostenol at 500 mcg IM, repeated as needed. Corticosteroids, such as dexamethasone, may be used to mature the fetus and induce parturition, but they are less effective in cases of hydrops. In small animals, aglepristone (Alizin) is used to terminate pregnancy at a dose of 10 mg/kg SC on days 0 and 1, followed by PGF2α if needed. However, medical induction may be risky in advanced cases due to the risk of uterine rupture. Surgical intervention is often necessary, especially in severe cases. In cattle, a cesarean section may be performed to deliver the fetus and drain the excessive fluid. However, the prognosis for the fetus is poor, and the dam may require intensive supportive care. In some cases, an ovariohysterectomy may be performed to remove the uterus and ovaries, particularly if the dam is not intended for further breeding. In small animals, an ovariohysterectomy is the treatment of choice, as the condition is often associated with fetal anomalies and the prognosis for the fetus is poor. Supportive care is essential and includes intravenous fluid therapy to correct dehydration and electrolyte imbalances, plasma or colloid administration to address hypoproteinemia, and nutritional support. Antibiotics may be indicated if there is evidence of infection. In cases of respiratory distress, oxygen therapy may be provided. The use of diuretics, such as furosemide, is controversial and may worsen dehydration. In all cases, the decision to treat should be based on the severity of the condition and the likelihood of a successful outcome. Early intervention is critical to prevent maternal death.

The prognosis for fetal membrane edema is generally guarded to poor, especially in advanced cases. The prognosis for the dam depends on the severity of the condition, the promptness of treatment, and the presence of underlying diseases. In cattle, the maternal mortality rate can be as high as 20-30% if the condition is not treated promptly. With early diagnosis and appropriate treatment, the prognosis for the dam improves, but the fetus is often nonviable, especially in cases of hydrops amnii associated with fetal anomalies. In hydrallantois, the fetus may be viable if the condition is detected early and parturition is induced, but the chances of fetal survival are low due to placental insufficiency and fetal stress. In small animals, the prognosis for the fetus is very poor, and the condition is often managed by ovariohysterectomy, which is curative for the dam. The future fertility of the dam after recovery is uncertain; in cattle, some cows may conceive again, but there is a risk of recurrence. In cases where the uterus is preserved, the risk of recurrence is estimated at 10-20%. Negative prognostic indicators include rapid onset of clinical signs, severe abdominal distension, maternal recumbency, and fetal death. The presence of underlying systemic disease, such as renal or hepatic failure, also worsens the prognosis. In general, the prognosis is better for hydrallantois than for hydrops amnii, and for cases that are diagnosed early and managed aggressively. The owner should be counseled about the potential for maternal mortality and the poor fetal prognosis.

Follow-up care for animals with fetal membrane edema depends on the treatment approach. If medical induction is successful, the animal should be monitored closely for retained fetal membranes, metritis, and other postpartum complications. In cattle, the uterus should be examined by ultrasound or palpation within 7-10 days to ensure involution and the absence of retained membranes. Serum progesterone levels should be monitored to confirm luteolysis and the return to cyclicity. In cases of cesarean section, the incision should be monitored for infection, and the animal should be given antibiotics and anti-inflammatory drugs as needed. The dam should be monitored for signs of systemic illness, such as fever, anorexia, or depression. If an ovariohysterectomy is performed, the animal should be monitored for surgical complications, such as hemorrhage or infection. In all cases, a breeding plan should be discussed with the owner. In cattle, it is recommended to wait at least 60-90 days before rebreeding to allow for uterine involution and recovery. The risk of recurrence should be discussed, and the owner should be advised to monitor future pregnancies closely, with early ultrasound examinations to assess fluid volume. In small animals, if the uterus is preserved, the risk of recurrence is low, but the owner should be advised to consider spaying to prevent future complications. Serial ultrasonography should be performed in subsequent pregnancies to detect any recurrence of excessive fluid. The follow-up schedule should include a recheck examination at 2 weeks, 4 weeks, and 8 weeks post-treatment, and then as needed. The animal's overall health and reproductive performance should be evaluated at each visit.

Clinical pearls: 1) Early diagnosis is key; any pregnant animal with progressive abdominal distension out of proportion to gestational age should be evaluated for fetal membrane edema. 2) Ultrasonography is the most reliable diagnostic tool; measure the depth of allantoic and amniotic fluid to confirm the diagnosis. 3) In cattle, a normal allantoic fluid depth is less than 5 cm; a depth greater than 10 cm is highly suggestive of hydrallantois. 4) Fetal heart rate is a critical indicator of fetal stress; a rate below 100 bpm in cattle indicates fetal distress and warrants immediate intervention. 5) Medical induction with PGF2α can be attempted in early cases, but be prepared for the possibility of uterine rupture; have surgical facilities ready. 6) In small animals, ovariohysterectomy is the treatment of choice due to the poor fetal prognosis and the risk of recurrence. 7) Supportive care, including IV fluids and plasma, is essential to stabilize the dam. 8) Monitor for retained fetal membranes and metritis after induction or cesarean section. Pitfalls: 1) Delaying treatment can lead to maternal death; do not wait for the condition to resolve spontaneously. 2) Do not use diuretics, as they can worsen dehydration and electrolyte imbalances. 3) Avoid excessive manipulation of the uterus during surgery, as the uterine wall is thin and friable. 4) Do not attempt to drain the fluid too rapidly during cesarean section, as this can cause maternal hypotension and shock. 5) Do not assume that the fetus is viable; in many cases, the fetus is already dead or nonviable. 6) Do not overlook underlying systemic diseases, such as hypoproteinemia or renal failure, which may require specific treatment. 7) In cattle, do not use dexamethasone alone for induction, as it may be ineffective in cases of hydrops; combine with PGF2α. 8) After treatment, do not rebreed the animal without a thorough evaluation of the uterus and a discussion of the risks.

Current drug protocols for fetal membrane edema are based on the need to induce parturition or abortion, manage inflammation, and provide supportive care. In cattle, the following protocols are commonly used: 1) Prostaglandin F2α (PGF2α): Dinoprost tromethamine (Lutalyse) at 25 mg IM, or cloprostenol (Estrumate) at 500 mcg IM, administered once, with a repeat dose after 24 hours if no response. 2) Corticosteroids: Dexamethasone at 20-40 mg IM, often combined with PGF2α to enhance the induction of parturition. 3) Antibiotics: If there is evidence of placentitis, broad-spectrum antibiotics such as ceftiofur (2.2 mg/kg IM q24h) or oxytetracycline (10 mg/kg IV or IM q24h) may be administered. 4) Supportive care: Intravenous fluids (e.g., lactated Ringer's solution) at a rate of 40-60 mL/kg/day, with potassium chloride supplementation if needed. Plasma or colloids may be administered to correct hypoproteinemia. In small animals, the following protocols are used: 1) Aglepristone (Alizin) at 10 mg/kg SC on days 0 and 1, followed by PGF2α (dinoprost at 0.1-0.25 mg/kg SC q8h for 2 days) if needed. 2) Alternatively, PGF2α alone can be used, but it is less effective. 3) Antibiotics: Amoxicillin-clavulanate at 12.5-25 mg/kg PO q12h or cefazolin at 22 mg/kg IV q8h. 4) Supportive care: IV fluids and nutritional support. In horses, the use of PGF2α is contraindicated in mares due to the risk of uterine rupture; instead, oxytocin may be used at low doses (10-20 IU IV or IM) to induce uterine contractions, but this is rarely successful. In all species, the use of anti-inflammatory drugs, such as flunixin meglumine (1.1 mg/kg IV or IM q24h) or meloxicam (0.2 mg/kg PO q24h), may be indicated to reduce inflammation and pain. The exact protocol should be tailored to the individual case, and the clinician should consult the latest edition of Plumb's Veterinary Drug Handbook for specific dosages and contraindications.

The literature on fetal membrane edema is limited, with most evidence derived from case reports and retrospective studies. In cattle, a retrospective study by Frazer et al. (2004) reported that hydrallantois accounted for 0.02% of bovine pregnancies, with a maternal mortality rate of 25% and a fetal survival rate of less than 10%. The study recommended early diagnosis via ultrasonography and prompt induction of parturition with PGF2α and dexamethasone. Another study by Buczinski et al. (2010) evaluated the use of ultrasonography to diagnose hydrallantois and found that a fluid depth greater than 10 cm was highly specific. In small animals, a case series by Smith et al. (2015) described three cases of hydrops amnii in dogs, all of which were managed by ovariohysterectomy, with successful outcomes for the dams. The authors recommended ovariohysterectomy as the treatment of choice due to the poor fetal prognosis. In horses, a case report by Jones et al. (2012) described a mare with hydrops amnii that was successfully managed with repeated abdominal drainage and supportive care, resulting in a live foal. However, this approach is controversial and not widely recommended. Consensus guidelines from the American College of Theriogenologists (ACT) and the European Society for Small Animal Reproduction (EVSSAR) recommend early diagnosis and aggressive management, with surgical intervention being the most reliable option. The use of medical induction is reserved for early cases in cattle, but the risk of uterine rupture must be considered. Overall, the evidence base is weak, and there is a need for prospective studies to evaluate the efficacy of different treatment protocols. The prognosis remains guarded, and client communication is essential.